6
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Serum lipoprotein levels in genetically hypercholesterolaemic RICO rats: effects of a high-sucrose-cholesterol diet without or with altered magnesium and fluoride content

, , , , &
Pages 495-503 | Received 09 Dec 1994, Accepted 07 Jun 1995, Published online: 08 Jul 2009

References

  • Mayes P A. Nutrition. Harper's biochemistry, 23rd ed., R K Murray, D K Granner, P A Mayes, V W Rodwell. Prentice Hall International, London 1993; 599–608
  • Bernstein D H, Sadowsky N, Hegsted D M, Guri C D, Stare F J. Prevalence of osteoporosis in high-and low-fluoride areas in North Dakota. J Am Med Ass 1966; 198: 499–504
  • Luoma H, Helminen S KJ, Ranta H, Rytömaa I, Meurman J H. Relationship between the fluoride and magnesium concentrations in drinking water and some components in serum related to cardiovascular diseases in men from four rural districts in Finland. Scand J Clin Lab Invest 1973; 32: 217–24
  • Luoma H, Aromaa A, Helminen S, Murtomaa H, Kiviluoto L, Punsar S, et al. Risk of myocardial infarction in Finnish men in relation to fluoride, magnesium and calcium concentration in drinking water. Acta Med Scand 1983; 213: 171–6
  • Schmidt C W. Fluorbelastung des organismus und Aortensklerose—Gibt es da Zusammenhange?. Zeitschr Alternforsch 1988; 43: 203–6
  • Seelig M S. Magnesium deficiency in the pathogenesis of cardiovascular disease. Part II In: Seelig MS. Magnesium deficiency in the pathogenesis of disease. Early roots of cardiovascular, skeletal and renal abnormalities. Plenum, New York 1980; 141–264
  • Marier J R, Neri L C, Anderson T W. Water hardness, human health and the importance of magnesium. National Research Council Canada, Ottawa 1979
  • Karppanen H. Epidemiological studies on the relationship between magnesium intake and cardiovascular diseases. Artery 1981; 9: 190–9
  • Masironi R, Shaper A G. Epidemiological studies of health effects of water from different sources. Ann Rew Nutr 1981; 1: 375–400
  • Durlach J. Magnesium in clinical practice. John Libbey, London 1988
  • Rayssiguier Y. Role of magnesium and potassium in the pathogenesis of arteriosclerosis. Magnesium 1984; 3: 226–38
  • Rayssiguier Y. Magnesium, lipids and vascular diseases. Experimental evidence in animal models. Magnesium 1986; 5: 182–190
  • Britton W M, Stokstad E RL. Aorta and other soft tissue calcification in the magnesium-deficient rat. J Nutr 1970; 100: 1501–6
  • Pyke R E. Relationships of calcium, phosphorus, magnesium, and fluoride in hard- and soft-tissue calcification. Biological mineralization, I Zipkin. John Wiley, New York 1973; 463–85
  • Luoma H. Fluoride in human health and diseases. Mineral elements ′80, Part II. A Nordic symposium on soil-plant-animal-man interrelationships and implications to human health. Helsinki. the Academy of Finland, Nordforsk 1981; 349–64, et al.
  • Luoma H. Risk of myocardial infarction in relation to magnesium and calcium concentrations in drinking water, with some aspects on the magnesium vs. fluoride interactions. Magnesium in health and disease, Y Itokawa, J Durlach. John Libbey, London 1989; 183–190
  • Townsend D W, Singer L. Effect of fluoride on the serum lipids of guinea pigs. J Nutr 1977; 107: 97–103
  • Vatassery G T, Ophaug R H, Singer L. The effect of fluoride intake on the total lipid, cholesterol and vitamin E levels in sera and liver of guinea pigs on high fat diet. Life Sci 1980; 27: 1961–6
  • Singh J P, Shashi X, Thapar S P. Effect of fluoride on total lipid, cholesterol and triglyceride levels in liver of albino rabbits. Fluoride 1985; 18: 146–8
  • Muller K R, Li J R, Dinh D M, Subbiah M TR. The characteristics and metabolism of a genetically hypercholesterolemic strain of rat (RICO). Biochim Biophys Acta 1979; 574: 334–43
  • Cardona-Sanclemente L E, Ferezou J, Lutton C. Cholesterol metabolism in the genetically hyper-cholesteremic (RICO) rat. II. A study of plasma lipoproteins and the effect of dietary cholesterol. Biochim Biophys Acta 1988; 960: 382–9
  • Navia J M, Lopez H, Harris R S. Purified diet for caries studies with rats. J Nutr 1969; 97: 133–40
  • Havel R J, Eder H A, Bragdon J H. The determination and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955; 34: 1345–53
  • Röschlau P, Bernt E, Gruber W. Enzymatische Bestimmung des Gesamtcholesterins im Serum. Z Klin Chem Klin Biochem 1974; 12: 226–30
  • Wahlefeld A W. Triglycerides: determination after enzymatic hydrolysis. Methods for enzymatic analysis, H U Bergmeyer. Academic Press, New York 1974; 18–31
  • Takayama M, Itoh S, Nagasaki T, Tanimizu I. A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 1977; 79: 93–8
  • Jauhiainen M, Metso J, Pahlman R, Blomqvist S, van Tol A, Ehnholm C. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. J Biol Chem 1993; 268: 4032–6
  • Dullaart R PF, Sluiter W J, Dikkeschei L D, Hoogenberg K, van Tol A. Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism. Eur J Clin Invest 1994; 24: 188–194
  • Metabolic basis of inherited disease. Part W. Disorders of lipoprotein and lipid metabolism, J B Stanbury, J P Wyngaarden, D S Fredrickson, J L Goldstein, M S Brown. McGraw-Hill, New York 1983; 589–79
  • Rayssiguier Y, Gueux E, Weiser D. Effects of magnesium deficiency on lipid metabolism in rats fed a high-carbohydrate diet. J Nutr 1981; 111: 1876–83
  • Methods for clinical laboratory measurement of lipid and lipoprotein risk factors, N Rifari, R Warnick. AACC Press, Washington 1993
  • Allmann D W, Miller A, Kleiner H S. Effect of fluoridated water on 3′5′ cyclic AMP levels in various rat tissues. J Dent Res 1978; 57: 881
  • Singh M, Susheela A K. Adenyl cyclase activity and cyclic AMP levels following F ingestion in rabbits and human subjects. Fluoride 1982; 15: 202–8
  • Strochkova L S, Zhavoronkov A A. Fluoride as an activator of enzymatic systems. Fluoride 1983; 16: 181–6
  • Kleiner H S, Allmann D W. The effects of fluoridated water on rat urine and tissue cAMP levels. Arch Oral Biol 1982; 27: 107–12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.